Fatigue News and Research

RSS

Sleep apnea and driving

Obstructive Sleep Apnea (OSA) is a disease that not many people know about although they may even suffer from it.

21 Nov 2007

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Exercise and education improves function and symptoms in women with fibromyalgia

An exercise program that incorporates walking, strength training and stretching may improve daily function and alleviate symptoms in women with fibromyalgia, according to a report in the November 12, 2007 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Nov 2007

Nausea during chemo may be worse with psychological problems

A group of Danish researchers has investigated the psychological circumstances of nausea during chemotherapy in cancer patients and has reported the findings in the current issue of Psychotherapy and Psychosomatics.

13 Nov 2007

FDA strengthens warnings for erythropoiesis-stimulating agents

The U.S. Food and Drug Administration has approved revised boxed warnings and other safety-related product labeling changes for erythropoiesis-stimulating agents (ESAs), which treat certain types of anemia.

13 Nov 2007

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Heart plays a losing game of catch-up as people age

Researchers at Johns Hopkins have evidence to explain why the supposedly natural act of aging is by itself a very potent risk factor for life-threatening heart failure.

5 Nov 2007

Anti-leukemia drug dexamethasone increases patient fatigue

The anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL), according to a new study from St. Jude Children's Research Hospital.

2 Nov 2007

Fibromyalgia pain caused by neuron mismatch

The unexplained pain experienced by patients with fibromyalgia is the result of a mismatch between sensory and motor systems, new research suggests.

31 Oct 2007

DIY liver test tells you how damage has been done

According to the manufacturers, a simple DIY test can tell drinkers how much damage has been done to their livers.

30 Oct 2007

Tasigna gets the green light in the U.S. to treat Chronic Myeloid Leukemia

The Food and Drug Administration (FDA) in the U.S. has given approval for a new drug to treat chronic myeloid leukemia (CML).

30 Oct 2007

Preventing lung scarring may extend lives of lung cancer patients

Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients – pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

One-third of Americans under extreme stress

According to the latest survey as many as one-third of American adults is under extreme stress.

29 Oct 2007

FDA warns about 'stay awake drug' Provigil

The U.S. Food and Drug Administration (FDA) has issued a warning in connection with the drug Provigil because of dangerous side effects.

28 Oct 2007

Exercise and counseling could ease cancer-related fatigue

Cancer patients suffering from symptoms of fatigue might find some relief through regular exercise and psychological counseling to deal with stress, according to a new review.

24 Oct 2007

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

The U.S. Food and Drug Administration has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.

22 Oct 2007

Sanofi Pasteur receives FDA approval of Menactra meningococcal vaccine for children

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.

22 Oct 2007

Psychosocial and psychological interventions for treating postpartum depression

For the estimated 13 percent of new mothers who experience postpartum depression, counseling and peer support groups appear to offer symptom relief without medication, a new review of research suggests.

17 Oct 2007

Usage of complementary and alternative medicine therapies high among those with obstructive sleep apnea hypopnea syndrome

A high proportion of patients with obstructive sleep apnea hypopnea syndrome (OSAHS) report previous or current use, and interest in future use, of complementary and alternative medicine (CAM) therapies, according to a study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM).

16 Oct 2007